CuraLinc Healthcare, a leading provider of mental health and wellbeing programs for employees, students and families, and Lightyear Capital (“Lightyear”), a New York-based private equity firm, today announced the strategic acquisition of Marquee Health (“Marquee”), a premier provider of corporate wellness and health coaching services. The acquisition further strengthens CuraLinc’s ability to offer a fully integrated, holistic approach to wellness that supports physical, mental and emotional wellbeing. 

The combined company will provide comprehensive, personalized solutions to over 6,000 clients and more than 10 million members, engaging and empowering individuals at every stage of their health and wellness journey. Together, CuraLinc and Marquee will deliver an enhanced spectrum of services, including mental health counseling, health coaching, biometric screenings, lifestyle management and wellness incentive programs.

“By integrating Marquee’s expertise in physical health and wellness with CuraLinc’s industry-leading mental health solutions, we are creating a truly comprehensive wellbeing solution,” said Sean Fogarty, President and Chief Executive Officer of CuraLinc. “This acquisition enables us to better serve our clients by providing seamless, data-driven care that improves outcomes and lowers health care costs.”

“For the past 10 years, we have partnered closely with CuraLinc to bring industry-leading mental health services to our mutual clients,” said Jonathon Short, Founder and President of Marquee Health. “Together, we can now offer a full continuum of care that addresses every aspect of wellbeing, from mental and emotional support to physical health and preventive treatment.”

The acquisition of Marquee Health marks a significant milestone for CuraLinc, as the company continues to grow and expand its service offerings under the leadership of Lightyear Capital, CuraLinc’s primary investor. “This partnership will accelerate our growth and innovation, enabling us to provide more meaningful and measurable solutions for our clients,” said Fogarty.

CuraLinc and Marquee have worked together for many years, sharing clients and collaborating on wellness initiatives. The acquisition formalizes this long-standing partnership, ensuring that clients and their employees benefit from a more robust, integrated solution designed to enhance employee engagement and improve overall health outcomes.

Marquee represents CuraLinc’s first acquisition in partnership with Lightyear. Troutman Pepper Hamilton Sanders LLP and Davis Polk & Wardwell LLP served as legal advisors to CuraLinc and Lightyear. Locke Lord LLP served as legal counsel and The Chicago Corporation served as Marquee’s financial advisor. Terms of the transaction were not disclosed.